Advert - Boehringer Ingelheim

For commissioning an article in a medical journal which was disguised promotion of Trajenta before the grant of a marketing authorization that permitted its sale or supply, Boehringer Ingelheim was ruled in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry

Clause 3.1 - Promoting a medicine before the grant of a marketing authorization

Clause 7.2 - Making an inaccurate claim

Clause 7.4 - Making an unsubstantiated claim

Clause 7.9 - Making an unsubstantiated claim about the comparative safety of a medicine

Clause 7.10 - Making a claim for a special merit which could not be substantiated

Clause 9.1 - Failing to maintain high standards

Clause 9.10 - Failing to clearly indicate its sponsorship of material relating to medicines and their uses

Clause 12.1 - Disguising promotional materials.

Advert - February 2012